Patents Assigned to Kumquat Biosciences Inc.
  • Macrocyclic heterocycles and uses thereof
    Patent number: 11912708
    Abstract: The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
    Type: Grant
    Filed: June 2, 2023
    Date of Patent: February 27, 2024
    Assignee: KUMQUAT BIOSCIENCES INC.
    Inventors: Baogen Wu, Pingda Ren, Zhiyong Chen, Yi Liu
  • Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling
    Patent number: 11648254
    Abstract: The present disclosure provides compounds represented by Formula (I-1): and pharmaceutically acceptable salts thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: May 16, 2023
    Assignee: Kumquat Biosciences Inc.
    Inventors: Baogen Wu, Xiangzhu Wang, Xiaoming Li, Zhiyong Chen, Pingda Ren, Yi Liu